Similar articles

• Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.

  Medina Santillán R, Reyes-García G, Mateos-García E. Medina Santillán R, et al. Proc West Pharmacol Soc. 2002;45:139-40. Proc West Pharmacol Soc. 2002. PMID: 12434559 Clinical Trial. No abstract available.
• Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.

  Cunha MR, Silva ME, Machado HA, Fukui RT, Correia MR, Santos RF, Wajchenberg BL, Rocha DM, Rondon MU, Negrão CE, Ursich MJ. Cunha MR, et al. Diabetes Obes Metab. 2008 Mar;10(3):238-45. doi: 10.1111/j.1463-1326.2006.00690.x. Diabetes Obes Metab. 2008. PMID: 18269639 Clinical Trial.
• Glyburide/metformin (Glucovance) for type 2 diabetes.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2000 Nov 13;42(1092):105-6. Med Lett Drugs Ther. 2000. PMID: 11077467 No abstract available.
• Glyburide/metformin HCl clinical overview.

  Seymour A. Seymour A. Manag Care. 2001 Feb;10(2 Suppl):11-6. Manag Care. 2001. PMID: 11729403 Review. No abstract available.
• Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes.

  Dailey GE. Dailey GE. Expert Opin Pharmacother. 2003 Aug;4(8):1417-30. doi: 10.1517/14656566.4.8.1417. Expert Opin Pharmacother. 2003. PMID: 12877648 Review.